212 related articles for article (PubMed ID: 21228582)
1. A quantitative approach to drug dosing in chronic kidney disease.
Olyaei AJ; Steffl JL
Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
[TBL] [Abstract][Full Text] [Related]
2. Drug dosing guidelines in patients with renal failure.
Swan SK; Bennett WM
West J Med; 1992 Jun; 156(6):633-8. PubMed ID: 1615656
[TBL] [Abstract][Full Text] [Related]
3. Drug dosing in chronic kidney disease.
Gabardi S; Abramson S
Med Clin North Am; 2005 May; 89(3):649-87. PubMed ID: 15755472
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
Velenosi TJ; Urquhart BL
Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
[TBL] [Abstract][Full Text] [Related]
5. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
[TBL] [Abstract][Full Text] [Related]
6. Drug dosing adjustments in patients with chronic kidney disease.
Munar MY; Singh H
Am Fam Physician; 2007 May; 75(10):1487-96. PubMed ID: 17555141
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. Compliance with dosing guidelines in patients with chronic kidney disease.
Long CL; Raebel MA; Price DW; Magid DJ
Ann Pharmacother; 2004 May; 38(5):853-8. PubMed ID: 15054147
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A
G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740
[TBL] [Abstract][Full Text] [Related]
10. Disease management in chronic kidney disease.
Rastogi A; Linden A; Nissenson AR
Adv Chronic Kidney Dis; 2008 Jan; 15(1):19-28. PubMed ID: 18155106
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
Shah RR
Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
[TBL] [Abstract][Full Text] [Related]
12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
13. Drug dosing in patients with impaired renal function.
Brater DC
Clin Pharmacol Ther; 2009 Nov; 86(5):483-9. PubMed ID: 19626002
[TBL] [Abstract][Full Text] [Related]
14. Optimal medication dosing in patients with diabetes mellitus and chronic kidney disease.
MacCallum L
Can J Diabetes; 2014 Oct; 38(5):334-43. PubMed ID: 25284697
[TBL] [Abstract][Full Text] [Related]
15. Drug dosing in patients with renal insufficiency. A simplified approach.
Bakris GL; Talbert R
Postgrad Med; 1993 Dec; 94(8):153-6, 159-60, 163-4. PubMed ID: 8247992
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics in patients with renal failure.
Maher JF
Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
[TBL] [Abstract][Full Text] [Related]
17. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
Lalonde RL; Wagner JA
Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
[TBL] [Abstract][Full Text] [Related]
18. Understanding renal replacement therapy and dosing of drugs in pediatric patients with kidney disease.
Zuppa AF
J Clin Pharmacol; 2012 Jan; 52(1 Suppl):134S-40S. PubMed ID: 22232749
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
20. Drug dosing in continuous renal replacement therapy: general rules.
Schetz M
Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
